This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992:94:309-15.

doi: 10.1016/s0079-6123(08)61760-4.

Neuronal and astroglial monoamine oxidase: pharmacological implications of specific MAO-B inhibitors

P H Yu¹, B A Davis, A A Boulton

Affiliations

PMID: 1287721
DOI: 10.1016/s0079-6123(08)61760-4

Review

Neuronal and astroglial monoamine oxidase: pharmacological implications of specific MAO-B inhibitors

P H Yu et al. Prog Brain Res. 1992.

. 1992:94:309-15.

doi: 10.1016/s0079-6123(08)61760-4.

Authors

P H Yu¹, B A Davis, A A Boulton

Affiliation

¹ Neuropsychiatric Research Unit, University of Saskatchewan, Saskatoon, Canada.

PMID: 1287721
DOI: 10.1016/s0079-6123(08)61760-4

No abstract available

PubMed Disclaimer

Similar articles

The effect of deprenyl (selegiline) on intra- and extraneuronal dopamine oxidation.
Oreland L, Arai Y, Stenström A. Oreland L, et al. Acta Neurol Scand Suppl. 1983;95:81-5. doi: 10.1111/j.1600-0404.1983.tb01518.x. Acta Neurol Scand Suppl. 1983. PMID: 6428149
N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS, Jinsmaa Y, Sullivan P, Sharabi Y. Goldstein DS, et al. Neurochem Res. 2017 Nov;42(11):3289-3295. doi: 10.1007/s11064-017-2371-0. Epub 2017 Aug 24. Neurochem Res. 2017. PMID: 28840582 Free PMC article.
Type B and A monoamine oxidase and their inhibitors regulate the gene expression of Bcl-2 and neurotrophic factors in human glioblastoma U118MG cells: different signal pathways for neuroprotection by selegiline and rasagiline.
Inaba-Hasegawa K, Shamoto-Nagai M, Maruyama W, Naoi M. Inaba-Hasegawa K, et al. J Neural Transm (Vienna). 2017 Sep;124(9):1055-1066. doi: 10.1007/s00702-017-1740-9. Epub 2017 Jun 2. J Neural Transm (Vienna). 2017. PMID: 28577058
A review of the mechanisms and role of monoamine oxidase inhibitors in Parkinson's disease.
Youdim MB, Riederer PF. Youdim MB, et al. Neurology. 2004 Oct 12;63(7 Suppl 2):S32-5. doi: 10.1212/wnl.63.7_suppl_2.s32. Neurology. 2004. PMID: 15477584 Review. No abstract available.
Deprenyl as prophylaxis against Parkinson's disease?
Sonsalla PK, Golbe LI. Sonsalla PK, et al. Clin Neuropharmacol. 1988 Dec;11(6):500-11. doi: 10.1097/00002826-198812000-00003. Clin Neuropharmacol. 1988. PMID: 3148365 Review. No abstract available.

See all similar articles

Cited by

In vivo quantification of monoamine oxidase A in baboon brain: a PET study using [(11)C]befloxatone and the multi-injection approach.
Bottlaender M, Valette H, Delforge J, Saba W, Guenther I, Curet O, George P, Dollé F, Grégoire MC. Bottlaender M, et al. J Cereb Blood Flow Metab. 2010 Apr;30(4):792-800. doi: 10.1038/jcbfm.2009.242. Epub 2009 Nov 18. J Cereb Blood Flow Metab. 2010. PMID: 19920845 Free PMC article.
Reactive Oxygen Species: Physiological and Physiopathological Effects on Synaptic Plasticity.
Beckhauser TF, Francis-Oliveira J, De Pasquale R. Beckhauser TF, et al. J Exp Neurosci. 2016 Sep 4;10(Suppl 1):23-48. doi: 10.4137/JEN.S39887. eCollection 2016. J Exp Neurosci. 2016. PMID: 27625575 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science